CO5360641A1 - Compuestos quimicos - Google Patents
Compuestos quimicosInfo
- Publication number
- CO5360641A1 CO5360641A1 CO00097282A CO00097282A CO5360641A1 CO 5360641 A1 CO5360641 A1 CO 5360641A1 CO 00097282 A CO00097282 A CO 00097282A CO 00097282 A CO00097282 A CO 00097282A CO 5360641 A1 CO5360641 A1 CO 5360641A1
- Authority
- CO
- Colombia
- Prior art keywords
- chemical compounds
- compounds
- methods
- farnesylation
- fptase
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 230000006126 farnesylation Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000004030 farnesyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9930318.2A GB9930318D0 (en) | 1999-12-22 | 1999-12-22 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5360641A1 true CO5360641A1 (es) | 2004-01-30 |
Family
ID=10866834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO00097282A CO5360641A1 (es) | 1999-12-22 | 2000-12-22 | Compuestos quimicos |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7101897B2 (enExample) |
| EP (1) | EP1255733B1 (enExample) |
| JP (1) | JP3742593B2 (enExample) |
| KR (1) | KR20020063251A (enExample) |
| CN (2) | CN1229344C (enExample) |
| AR (1) | AR029460A1 (enExample) |
| AT (1) | ATE316074T1 (enExample) |
| AU (1) | AU776003B2 (enExample) |
| BR (1) | BR0016669A (enExample) |
| CA (1) | CA2387579A1 (enExample) |
| CO (1) | CO5360641A1 (enExample) |
| CZ (1) | CZ20022125A3 (enExample) |
| DE (1) | DE60025650D1 (enExample) |
| EE (1) | EE200200206A (enExample) |
| GB (1) | GB9930318D0 (enExample) |
| HU (1) | HUP0204135A3 (enExample) |
| IL (1) | IL149871A0 (enExample) |
| IS (1) | IS6358A (enExample) |
| MX (1) | MXPA02005981A (enExample) |
| MY (1) | MY133606A (enExample) |
| NO (1) | NO20022924L (enExample) |
| NZ (1) | NZ518341A (enExample) |
| PL (1) | PL355887A1 (enExample) |
| RU (1) | RU2259997C2 (enExample) |
| SK (1) | SK8642002A3 (enExample) |
| WO (1) | WO2001046137A1 (enExample) |
| ZA (1) | ZA200202694B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005117864A1 (en) * | 2004-05-28 | 2005-12-15 | Astrazeneca Ab | Combination product comprising anastrozole and a dual prenyl transferase inhibitor |
| WO2006038719A1 (ja) * | 2004-10-08 | 2006-04-13 | Kotobuki Pharmaceutical Co., Ltd. | ホスホン酸誘導体及び血中の高リン酸が関与する疾患の治療剤 |
| US20110136867A1 (en) * | 2006-02-02 | 2011-06-09 | Justman Craig J | Treatment of Synucleinopathies |
| WO2009151683A2 (en) | 2008-03-12 | 2009-12-17 | Link Medicine Corporation | Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications |
| WO2010057006A1 (en) | 2008-11-13 | 2010-05-20 | Link Medicine Corporation | Azaquinolinone derivatives and uses thereof |
| US8975247B2 (en) | 2009-03-18 | 2015-03-10 | The Board Of Trustees Of The Leland Stanford Junion University | Methods and compositions of treating a flaviviridae family viral infection |
| WO2011088126A2 (en) * | 2010-01-13 | 2011-07-21 | Eiger Biopharmaceuticals, Inc. | Treatment of viral infection with prenyltransferase inhibitors |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU422723A1 (ru) * | 1972-03-29 | 1974-04-05 | Б. В. Салов, Т. А. Губенкова , И. В. Быховска | Способ получения 5-нитро-2-аминобензойнойкислоты |
| CA1283906C (en) | 1983-05-09 | 1991-05-07 | Makoto Sunagawa | .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF |
| JPS60233076A (ja) | 1984-05-03 | 1985-11-19 | Sumitomo Chem Co Ltd | 新規なβ−ラクタム化合物およびその製造法 |
| EP0182213B1 (en) | 1984-11-08 | 1990-09-26 | Sumitomo Pharmaceuticals Company, Limited | Carbapenem compounds and production thereof |
| KR880006244A (ko) | 1986-11-24 | 1988-07-22 | 후지사와 도모 기찌 로 | 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법 |
| GB8921635D0 (en) | 1989-09-25 | 1989-11-08 | Fujisawa Pharmaceutical Co | 3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives |
| CA2036163C (en) | 1990-02-14 | 2001-06-19 | Makoto Sunagawa | Novel beta-lactam compounds and their production |
| FI96863C (fi) | 1990-02-23 | 1996-09-10 | Sankyo Co | Menetelmä lääkeaineina käyttökelpoisten /2-(1-homopiperatsiinikarbonyyli)pyrrolidin-4-yylitio/-6-(1-hydroksietyyli)-1-karbapen-2-eemi-3-karboksylaattisuolojen valmistamiseksi |
| GB9107363D0 (en) | 1991-04-08 | 1991-05-22 | Ici Plc | Antibiotic compounds |
| US6083917A (en) | 1990-04-18 | 2000-07-04 | Board Of Regents, The University Of Texas System | Methods and compositions for the identification, characterization and inhibition of farnesyltransferase |
| US5185248A (en) | 1990-05-08 | 1993-02-09 | E. R. Squibb & Sons, Inc. | Farnesyl-protein transferase assay for identifying compounds that block neoplastic transformation |
| JPH0578360A (ja) | 1991-01-31 | 1993-03-30 | Banyu Pharmaceut Co Ltd | ２−［２−（スルフアモイルアルキル）ピロリジニルチオカルバペネム誘導体 |
| GB9107341D0 (en) | 1991-04-08 | 1991-05-22 | Ici Plc | Antibiotic compounds |
| GB9107342D0 (en) | 1991-04-08 | 1991-05-22 | Ici Plc | Antibiotic compounds |
| AU651887B2 (en) | 1991-06-04 | 1994-08-04 | Sankyo Company Limited | 1-methylcarbapenem derivatives, their preparation and their use as antibiotics |
| JPH04368386A (ja) | 1991-06-18 | 1992-12-21 | Sankyo Co Ltd | １−メチルカルバペネム−３−カルボン酸の製造法 |
| US5360798A (en) | 1991-07-04 | 1994-11-01 | Shionogi Seiyaku Kabushiki Kaisha | Aminooxypyrrolidinylthiocarbapenem compounds |
| DE69204007T2 (de) | 1991-10-11 | 1996-03-21 | Squibb & Sons Inc | Verwendung von Farnesyl-Protein Transferaseinhibitoren zur Herstellung eines Arzneimittels zur Blockierung von durch Ras-Oncogenen hervorgerufenen neoplastischen Transformationen von Zellen. |
| JPH05239058A (ja) | 1991-12-17 | 1993-09-17 | Fujisawa Pharmaceut Co Ltd | ３−ピロリジニルチオ−１−アザビシクロ［３．２．０ヘプト−２−エン−２−カルボン酸化合物 |
| GB9202298D0 (en) | 1992-02-04 | 1992-03-18 | Ici Plc | Antibiotic compounds |
| CZ290002B6 (cs) | 1992-03-11 | 2002-05-15 | Sankyo Company Limited | Antimikrobiální karbapenemové deriváty, způsob výroby a farmaceutický prostředek |
| GB9304156D0 (en) | 1992-03-26 | 1993-04-21 | Zeneca Ltd | Antibiotic compounds |
| CA2091309A1 (en) | 1992-03-26 | 1993-09-27 | Frederic H. Jung | Antibiotic compounds |
| JP3367104B2 (ja) | 1992-04-13 | 2003-01-14 | 藤沢薬品工業株式会社 | 抗菌剤としての置換された３−ピロリジニルチオ−カルバペネム化合物 |
| EP0581501B1 (en) | 1992-07-21 | 1998-09-09 | Zeneca Limited | Antibiotic carbapenem compounds |
| EP0581502B1 (en) | 1992-07-21 | 1998-10-21 | Zeneca Limited | Antibiotic carbapenem compounds |
| CA2099818A1 (en) | 1992-07-21 | 1994-01-22 | Frederic H. Jung | Antibiotic compounds |
| EP0590885B1 (en) | 1992-09-28 | 2000-03-15 | Zeneca Limited | Antibiotic carbapenem compounds |
| CA2106330A1 (en) | 1992-10-07 | 1994-04-08 | Patrice J. Siret | Antibiotic compounds |
| CA2118985A1 (en) | 1993-04-02 | 1994-10-03 | Dinesh V. Patel | Heterocyclic inhibitors of farnesyl protein transferase |
| CA2165176A1 (en) | 1993-06-18 | 1995-01-05 | Samuel L. Graham | Inhibitors of farnesyl-protein transferase |
| JP2534823B2 (ja) | 1993-07-07 | 1996-09-18 | 日本電気株式会社 | 印刷装置 |
| US5468733A (en) | 1993-09-30 | 1995-11-21 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| EP0725650A4 (en) | 1993-09-30 | 1999-02-03 | Merck & Co Inc | INHIBITORS OF FARNESYL PROTEIN TRANSFERASE |
| CA2155448A1 (en) | 1994-08-11 | 1996-02-12 | Katerina Leftheris | Inhibitors of farnesyl protein transferase |
| US5571835A (en) | 1994-09-29 | 1996-11-05 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| EP0817630A4 (en) | 1995-03-29 | 1999-01-27 | Merck & Co Inc | INHIBITORS OF FARNESYL PROTEIN TRANSFERASE |
| BR9609744A (pt) | 1995-07-31 | 1999-03-02 | Shionogi & Co | Derivados de pirrolidina tendo atividade inibitória de fosfolipase a2 |
| GB9515975D0 (en) | 1995-08-04 | 1995-10-04 | Zeneca Ltd | Chemical compounds |
| NO307879B1 (no) * | 1995-09-18 | 2000-06-13 | Sankyo Co | Nye ureaderivater med ACAT-inhiberende aktivitet og farmasøytisk preparat inneholdende disse |
| JPH1050029A (ja) | 1996-05-28 | 1998-02-20 | Nobuyuki Higuchi | 情報記憶装置 |
| WO1998007692A1 (en) * | 1996-08-17 | 1998-02-26 | Zeneca Limited | 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors |
| US6414145B1 (en) | 1997-01-29 | 2002-07-02 | Zeneca Limited | Imidazolyl compounds as inhibitors of farnesyl-protein tranferase |
| AR015649A1 (es) | 1997-05-07 | 2001-05-16 | Univ Pittsburgh | Inhibidores de isoprenil-transferasas proteicas, composiciones que los comprenden y el uso de los mismos para la fabricacion de un medicamento |
| WO1999041235A1 (en) * | 1998-02-10 | 1999-08-19 | Astrazeneca Uk Limited | Farnesyl transferase inhibitors |
-
1999
- 1999-12-22 GB GBGB9930318.2A patent/GB9930318D0/en not_active Ceased
-
2000
- 2000-12-18 PL PL00355887A patent/PL355887A1/xx not_active Application Discontinuation
- 2000-12-18 EE EEP200200206A patent/EE200200206A/xx unknown
- 2000-12-18 DE DE60025650T patent/DE60025650D1/de not_active Expired - Lifetime
- 2000-12-18 SK SK864-2002A patent/SK8642002A3/sk unknown
- 2000-12-18 CN CNB008174202A patent/CN1229344C/zh not_active Expired - Fee Related
- 2000-12-18 BR BR0016669-3A patent/BR0016669A/pt not_active IP Right Cessation
- 2000-12-18 AT AT00985605T patent/ATE316074T1/de not_active IP Right Cessation
- 2000-12-18 CN CNA2005100563322A patent/CN1680313A/zh active Pending
- 2000-12-18 NZ NZ518341A patent/NZ518341A/xx unknown
- 2000-12-18 IL IL14987100A patent/IL149871A0/xx unknown
- 2000-12-18 CA CA002387579A patent/CA2387579A1/en not_active Abandoned
- 2000-12-18 MX MXPA02005981A patent/MXPA02005981A/es unknown
- 2000-12-18 WO PCT/GB2000/004856 patent/WO2001046137A1/en not_active Ceased
- 2000-12-18 CZ CZ20022125A patent/CZ20022125A3/cs unknown
- 2000-12-18 AU AU22013/01A patent/AU776003B2/en not_active Ceased
- 2000-12-18 US US10/110,690 patent/US7101897B2/en not_active Expired - Fee Related
- 2000-12-18 EP EP00985605A patent/EP1255733B1/en not_active Expired - Lifetime
- 2000-12-18 RU RU2002119405/04A patent/RU2259997C2/ru not_active IP Right Cessation
- 2000-12-18 KR KR1020027008034A patent/KR20020063251A/ko not_active Ceased
- 2000-12-18 HU HU0204135A patent/HUP0204135A3/hu unknown
- 2000-12-18 JP JP2001547048A patent/JP3742593B2/ja not_active Expired - Fee Related
- 2000-12-20 MY MYPI20006011A patent/MY133606A/en unknown
- 2000-12-21 AR ARP000106845A patent/AR029460A1/es not_active Application Discontinuation
- 2000-12-22 CO CO00097282A patent/CO5360641A1/es not_active Application Discontinuation
-
2002
- 2002-04-05 ZA ZA200202694A patent/ZA200202694B/en unknown
- 2002-04-23 IS IS6358A patent/IS6358A/is unknown
- 2002-06-18 NO NO20022924A patent/NO20022924L/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9908280A (pt) | Inibidores de enzimas de fosfolipase | |
| DK1255537T3 (da) | Farnesylproteintransferasehæmmere til behandling af brystcancer | |
| ES2136037B1 (es) | Inhibidores de sulfamida-metaloproteasa | |
| ES2130452T3 (es) | Derivados de ciclobutano utilizados como inhibidores de la escualeno-sintetasa y de la farnesiltransferasa proteica. | |
| BR0104424A (pt) | Composições de pirazol úteis como inibidores de erk | |
| BRPI0418031A (pt) | inibidores de quinase fosfonato-substituìdos | |
| ES2171723T3 (es) | 3,4-diaril-2-hidroxi-2,5-dihidrofuranos como profarmacos de inhibidores de cox-2. | |
| BR9712831A (pt) | Inibidores tricìclicos de farnesil proteìna transferase | |
| NO20055863L (no) | W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer | |
| PT966465E (pt) | Inibidores do enzima imfdh | |
| ATE299854T1 (de) | Chinonverbindungen zur behandlung von krankheiten | |
| ATE323490T1 (de) | Farnesyl-protein-transferasehemmer zur behandlung der entzündlichen darmerkrankung | |
| ATE438618T1 (de) | Inhibitoren von humanem adam-10 | |
| ATE282607T1 (de) | Tryptase-inhibitoren | |
| CO5360641A1 (es) | Compuestos quimicos | |
| DK1105114T3 (da) | Nimesulidholdige topiske farmaceutiske sammensætninger | |
| BR0309386A (pt) | Inibidores de metaloproteinases de triaril-óxi-arilóxi-pirimidina-2,4,6-triona | |
| ES2147973T3 (es) | Estirenos alquilatados como profarmacos de inhibidores de cox-2. | |
| ES2182035T3 (es) | Derivados del bisarilciclobuteno como inhibidores de ciclooxigenasa. | |
| HN1998000091A (es) | Inhibidores de la farnesil transferasa tratamiento del cancer. | |
| NO983511D0 (no) | Difenylstilbener som pro-legemidler for COX-2-inhibitorer | |
| TR200200494T2 (tr) | Yağlı asit sintazı inhibitörleri. | |
| BR9909237A (pt) | Inibidores de farnesil-proteìna transferase | |
| DE69941292D1 (de) | Schlange, pseudonaja textilis textilis | |
| ES2183346T3 (es) | Sistemas conjugados de bis-fosfonato con restos alquilantes que tienen actividad antitumoral. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |